Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532655) titled 'A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Condition: Overweight or Obesity

Intervention: Drug: SYH2082 Injection

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: April 14, 2026

Target Sample Size: 44

To know more, visit https://clinicaltrials.gov/study/...